Fig. 4

A risk scoring system was derived from the prognostic 6-mRNAs signature. a The risk score distribution on the basis of the 6-mRNAs signature; b the vital status of 156 patients with HER2-positive breast cancer in high- and low-risk groups; c Heatmap of the 6-mRNAs expression genomes in low- and high-risk levels